跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin
Jui Chieh Chen
, Hsun Chang Shih
, Chih Yang Lin
, Jeng Hung Guo
,
Cheng Huang
, Hsiu Chen Huang
, Zhi Yong Chong
, Chih Hsin Tang
*
*
此作品的通信作者
醫學生物技術暨檢驗學系
研究成果
:
Article
›
同行評審
12
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Doxorubicin-resistant
100%
Chondrosarcoma Cells
100%
Apelin
100%
MicroRNA-631
100%
Chondrosarcoma
27%
Resistant Cells
18%
Doxorubicin
18%
Drug Resistance
18%
Doxorubicin-resistant Cells
18%
Clinical Treatment
9%
MicroRNA
9%
Clinical Setting
9%
Adipokines
9%
Therapeutic Benefits
9%
In Cancer
9%
Overexpression
9%
Therapeutic Strategies
9%
Metastasis
9%
Patient Survival
9%
Biological Activity
9%
Effective Treatment
9%
RNA Sequencing (RNA-seq)
9%
Pathway Inhibitors
9%
Bioinformatics Tools
9%
Bone Cancer
9%
In Vitro Experiment
9%
Most Common Form
9%
Chemotherapy Drugs
9%
Surgical Resection
9%
Resistant Cell Lines
9%
SW1353 Cells
9%
High-grade Chondrosarcoma
9%
Doxorubicin Sensitivity
9%
Multifunctional Activities
9%
Biomarker Strategy
9%
Tissue Array Analysis
9%
Secreted Peptides
9%
Resistance Biomarkers
9%
Medicine and Dentistry
microRNA
100%
Doxorubicin
100%
Chondrosarcoma
100%
Apelin
100%
Drug Resistance
18%
RNA Sequence
9%
In Vitro
9%
Biological Marker
9%
Cancer
9%
Metastatic Carcinoma
9%
Adipocytokine
9%
Tissue Microarray
9%
Bone Cancer
9%
Chondrosarcoma Cell Line
9%
Doxorubicin-Resistant Cell Line
9%
Surgery
9%
Biological Activity
9%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Doxorubicin
100%
Chondrosarcoma
100%
Apelin
100%
Drug Resistance
18%
RNA-Sequencing
9%
Adipocytokine
9%
Biological Activity
9%
Chemotherapy
9%
Biological Marker
9%
Bone Cancer
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Apelin
100%
Doxorubicin
100%
Drug Resistance
18%
RNA Sequence
9%
Adipokine
9%
Tissue Microarray
9%
Bioinformatics
9%
Biological Activity
9%
Neuroscience
MicroRNA
100%
Doxorubicin
100%
Cell Line
18%
Drug Resistance
18%
In Vitro
9%
RNA Sequence
9%
Adipokine
9%
Immunology and Microbiology
Apelin
100%